The American Academy of Neurology (AAN) recently announced that it accepted eight of the Tisch MS Research Center of New York’s research abstracts to be presented at its 2015 Annual Meeting. This year marks the AAN’s 67 th Annual Meeting, which will be held April 18 th – 25 th at the Walter E...
Congratulations to Dr. Saud A. Sadiq who has been recognized in Castle Connolly's " America's Top Doctors " 14th ed. and "Top Doctors: New York Metro Area" 18th ed. The mission of Castle Connolly Medical Ltd. is to help consumers find the best healthcare. To this end, they publish a variety of...
Dr. Massimiliano Cristofanilli and Dr. Fozia Mir presented at the 2014 Society for Neuroscience Meeting in Washington D.C. on November 15 th . They spoke to an eager audience of over 200 scientists as part of the Demyelinating Disorders Nanosymposium. The annual meeting of the Society for...
On November 6, Neurology Today Online featured Tisch MSRCNY in a review of news coming out of the ACTRIMS/ECTRIMS Annual Meeting in September examining the safety of stem cell therapy in MS treatment. The article discussed two different trials that were found to be safe and well tolerated in...
Thank you to all who attended the 17th Annual Tisch MS Research Patient Symposium. In response to your requests, a review of the material presented will be posted on this website and appear in the next issue of our newsletter, Healing MS.
Dr. Violaine Harris and Dr. Saud A. Sadiq co-authored a review entitled “Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status and this has been accepted for publication in the Journal Molecular Diagnosis and Therapy . " Biomarkers of Therapeutic Response in Multiple Sclerosis:...
The journal Neurology® Neuroimmunology and Neuroinflammation accepted a paper by lead author Dr. Fozia Mir entitled, “Cerebrospinal fluid isoprostane levels are a biomarker of oxidative stress in multiple sclerosis.” The paper is authored by Dr. Mir, Donald Lee, Hetal Ray, and Saud A. Sadiq, MD and...